lobbying_activities: 1689570
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1689570 | 841047b9-c46b-4a4b-8500-dcfa61a3e62c | 2T | ANGELA STEWART | 401103673 | EISAI, INC | 2015 | second_quarter | MMM | Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs. Medicare Access and CHIP Reauthorization Act of 2015 (HR2) SGR Repeal and Medicare Provider Payment Modernization Act of 2015 (S810/HR1470) Treat and Reduce Obesity Act of 2015 (HR2404) | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 1 | 2015-06-11T16:00:20.950000-04:00 |